Coya Therapeutics
Houston
About Coya Therapeutics
Coya Therapeutics is a clinical-stage biotechnology company developing multiple first-in-class and best-in-class approaches that enhance regulatory T cells (Tregs) function in vivo, including allogeneic Treg-derived exosome therapeutics and novel biologics.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $95.9M
- Funding stage: IPO
- Last round: Post-IPO Equity (Jan 2026)
- Ticker: nasdaq:COYA
- Website: coyatherapeutics.com
- Phone: 1(800) 587-8570
Industries & Categories
Biopharma, Biotechnology, Life Science
Social Profiles
Canonical: https://fsome.com/organization/coya-therapeutics-102406 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.